跳至主要内容
临床试验/CTIS2024-511681-37-00
CTIS2024-511681-37-00进行中(未招募)1 期

Treatment with acetylcholine esterase inhibitors in anorexia nervosa : a multicenter double-blind randomised controlled trial versus placebo - D22-P020

Centre Hospitalier Sainte Anne Paris0 个研究点目标入组 111 人开始时间: 2024年3月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
111

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • female, Presence of 3 DSM V criteria for anorexia nervosa, Restrictive subtype of anorexia nervosa, Body Mass Index between 14 and 18.5 kg/m2, Aged between 18 and 65, Resting heart rate greater than or equal to 40 bpm

排除标准

  • Past diagnosis of anorexia nervosa in the form of hyperphagia/purgation, Pregnant or breast-feeding women, Past diagnosis of bulimia nervosa, Past diagnosis of binge eating disorder, Comorbid diagnosis of psychotic disorder and/or bipolar disorder, Renal impairment (glomerular filtration rate less than 60 mL/min according to the MDRD formula), Liver failure or transaminase elevation greater than 5N, Electrocardiogram of conduction disorder, Taking a psychotropic drug now or in the three weeks prior to inclusion (including antidepressants, to avoid interaction/potentiation in this population), Taking a treatment involving the following cytochromes : P450, P3A4, P2D6

研究者

发起方
Centre Hospitalier Sainte Anne Paris

相似试验

进行中(未招募)
1 期
Improving the blood pressure regulating system in patients with parkinsons diseaseOrtostatic hypotension in patients with Parkinsons diseaseMedDRA version: 14.1Level: PTClassification code 10031127Term: Orthostatic hypotensionSystem Organ Class: 10047065 - Vascular disorders
EUCTR2012-000122-21-DKDepartment of Neurology, Roskilde Hospital20
尚未招募
不适用
ong-term efficacy of acetylcholinesterase inhibitors on cognitive function. -Comparison between drugs.Altzheimer&#39s disease
JPRN-UMIN000014465Department of Neurology and Rheumatology, Shinshu University of Medicine300
进行中(未招募)
1 期
Die antidementive Therapie mit Acetylcholinesteraseinhibitoren: Untersuchung von Plasmakonzentrationen, Arzneimittelinteraktionen und Therapieeffekt in Abhängigkeit von genetischen PolymorphismeAnhand der vorliegenden Studie soll untersucht werden, ob genetische Polymorphismen im CYP2D6-, im MDR1- oder im ACHE Gen mit sub- bzw. supratherapeutischen Wirkstoffspiegeln im Plasma, mit relevanten Arzneimittelinteraktionen und/oder mit Unterschieden im klinischen Anprechen auf die antidementiv wirksamen Substanzen Donepezil Hydrochlorid, Galantamin Hydrobromid und Rivastigmin in Verbindung stehen.
EUCTR2008-005472-27-ATMedizinische Universität Innsbruck300
Unknown
4 期
Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum DisordersAutism
NCT01098383Sheba Medical Center84
进行中(未招募)
1 期
Rivastigmine as an early treatment for visual hallucinations in Parkinson’s disease (CHEVAL)MedDRA version: 18.0 Level: PT Classification code 10061536 Term: Parkinson's disease System Organ Class: 10029205 - Nervous system disordersParkinson's disease
EUCTR2013-001722-25-NLVU University Medical Center168